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Background: The study objective was to understand community preparedness for iron and folic acid (IFA)
supplementation early in pregnancy and to inform the design of a large-scale trial of early introduction of IFA
supplementation in rural Bangladesh.
Methods: 66 in-depth interviews (pregnant women, husbands, and older women in the household), 20
key-informant interviews, 3 focus-group discussions (community health workers and adolescent female students),
and observation of two community-based clinics were conducted.
Results: Most of the women who used IFA tablets during pregnancy reported better health and physical strength
after taking them. Women perceived that IFA increased blood volume, leading to foetal nourishment and
compensated for blood loss during delivery. However, a culturally informed perceived barrier was the belief that IFA
supplementation will increase foetus size, leading to birth complications, hospitalisation, caesarean section and
financial burden for the family. Community health workers (CHWs) of BRAC (a non-government organisation) were
the main sources of IFA information and supplements, although knowledge of IFA tablets among women’s social
networks also helped to make it acceptable. Pregnant women felt that they could start taking IFA during the first
trimester of pregnancy if advised by the CHWs. Programme managers and healthcare providers expressed concern
about starting IFA supplementation early.
Conclusion: Our study suggests that introduction of IFA supplementation early in pregnancy is feasible with support
from CHWs. Promotion of IFA could benefit from efforts to include culturally sensitive reasons for usage; improvement
of the CHW training modules; targeted home visits and counselling; and outreach to standardize messages.
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Iron-deficiency is the most widespread nutritional defi-
ciency globally and the most common cause of anaemia
during pregnancy [1-4]. It is highly prevalent and most se-
vere in pregnant women, infants, and children, as iron re-
quirement rises during these stages of life [5,6]. Globally,
38% (or about 32 million) of pregnant women were* Correspondence: neeloy.alam@sydney.edu.au
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unless otherwise stated.estimated to be anaemic in 2011 [7] and the deaths of
87,321 women worldwide were attributed to iron defi-
ciency [8]. Studies indicate that iron deficiency anaemia in
pregnancy is a risk factor for pre-term delivery [5], still-
birth [9], poor neonatal and infant health [10] and mater-
nal death during childbirth [11]. Researchers have also
reported that compared to women with normal iron sta-
tus, anaemic mothers give birth to a higher proportion of
low birth weight (LBW) babies [12-14], resulting in higher
perinatal morbidity and mortality and higher infant
mortality [14]. Anaemia in pregnancy also contributeshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Methods used and sample size
Methods Types of respondents Number
In-depth interviews Pregnant women 35
Older women 20
Fathers 11




Focus group discussions Frontline health worker (SS) 2
Female college students 1
Observation Community clinic 2
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tions [15], cognitive impairment [6] and losses in hu-
man and economic capital [16].
Iron supplementation, nutrition education (to encour-
age diversified diets), fortification of foods with iron, and
de-worming, done alone or in combination, are all ap-
proaches widely applied for controlling iron deficiency
anaemia during pregnancy [4]. In a review of iron-folic
acid (IFA) supplementation during pregnancy, researchers
reported a 70% reduction in anaemia at term, a 67% re-
duction in iron deficiency anaemia, and a 19% reduction
in the incidence of low birth weight [1,13]. Researchers
have identified lower risks of neonatal mortality in infants
for mothers who reported taking antenatal iron-folic acid
(IFA) supplements during pregnancy compared to those
who did not [17]. In Indonesia a 34% reduction in risk
of <5 child death was seen when the mother consumed
any IFA supplements during pregnancy [18]. This pro-
tective effect was greatest for deaths on the first day of
life (60% reduction) followed by deaths during 1–30
days of life (31% reduction), and deaths during the rest
of the neonatal period (26% reduction). Folic acid and
iron in combination was shown to be more effective
than iron or folic acid supplementation alone for the
treatment both of anaemia during pregnancy [19] and of
neonatal mortality [20].
Recently the World Health Organisation (WHO) rec-
ommended a standard daily dose of IFA supplementa-
tion throughout pregnancy starting as early as possible
to control iron deficiency [21]. A few studies indicated
that initiating IFA supplementation earlier in pregnancy
may provide increased benefits, such as prevention of
iron and folic acid deficiency during pregnancy [22] and
reduction of <5 mortality [18]. Despite these recommen-
dations, in many countries such as Bangladesh, women
start IFA supplementation after approximately twenty
weeks of gestation [22]. The Shonjibon trial – a large-scale
community-based randomised controlled trial of IFA sup-
plementation in rural Bangladesh – was designed to test
the hypothesis that initiation of IFA supplementation in
the first trimester will reduce neonatal mortality compared
to usual iron-folic acid supplementation programmes.
Our study was designed to explore benefits and challenges
around IFA supplementation during early pregnancy from
both community and service provider perspectives in
order to inform the design of the Shonjibon trial.
Methods
National and local context for IFA supplementation
Anaemia control received a place in Bangladesh’s National
Plan of Action for Nutrition from as early as 1997. In 2001
a National Guideline for the prevention and control of
iron deficiency anaemia was formulated. The goal of the
guideline is to reduce the prevalence of anaemia by one-quarter by 2015 [23]. The strategy to address this goal pays
special attention to children, pregnant women, lactating
women, adolescent girls, and married women (non-
pregnant) with no prescription about timing for starting
IFA supplementation. In national maternal health pro-
grammes, a standard formulation of IFA tablets with
60 mg of iron is available for distribution through differ-
ent public health facilities free of charge for daily sup-
plementation as soon as women come to the facilities
(usually during their second trimester). Several national
non-government organisations (NGOs) and the private
sector also provide IFA supplements to pregnant and lac-
tating women in both rural and urban areas of Bangladesh.
In the study areas, the facility-based national IFA distribu-
tion programme was supplemented by two NGOs - BRAC
and Shabolombi. The NGO workers made household
visits where they counselled pregnant women and sold
them various formulations of IFA tablets available in mar-
ket. Different types of IFA tablets were also available for
purchase from local pharmacies.Data collection
We collected data using qualitative methods. Data were
collected during July–October 2012. The field team con-
sisted of 3 women and 2 men with a master's degree in
anthropology or social science, as well as a few years of ex-
perience in collecting qualitative data. They were trained
and supervised by qualified anthropologists (NK, TS), a
medical anthropologist (AA) and a nutritionist (SR).
Four qualitative methods – in-depth interviews, key
informant interviews, focus group discussions and obser-
vations of the lowest level of health facility (community
clinics) were conducted (Table 1).
In-depth interviews were used to explore women’s and
family members’ perceptions of: cultural norms during
pregnancy; birth weight; IFA supplementation; and ex-
perience using IFA supplementation during pregnancy.
Key informant interviews were conducted to understand
the community norms around IFA supplementation and
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FGDs were used to understand both perceptions regard-
ing the need for IFA tablets during pregnancy and the
state of IFA supplementation programmes. An hour-
long observation was conducted in two community
clinics to understand how the national IFA programme
was being implemented.Study locations and populations
We conducted the fieldwork in two villages, one in
Mymensing and one in Netrokona– two of the five
districts included in the Shonjibon Trial– located in
north-central Bangladesh. One village in each district was
selected for the study. One of the authors (SR) and the
formative research field staff consulted the district man-
agers of the BRAC Health Programme to identify one
Upazilla (sub-district) from each district in which to con-
duct the fieldwork. The selected Upazillas best repre-
sented their districts in terms of demography, distance
from the district office of the NGOs headquarters, and
availability of health services from the Government and
NGOs. The research team then consulted with the re-
spective NGO Health Programme Managers to select one
village in each Upazilla for data collection.
Stratified purposeful and opportunistic sampling [24]
strategies were used to select the respondents. The
Programme Managers selected two community health
supervisors or Shasthya Kormis (SK) from each selected
village. Shasthya Shebikas or SS (frontline health workers
employed by BRAC) who worked under the supervision
of the selected SK in the village were interviewed. The
pregnant women were selected for the in-depth inter-
views from the registers of the SKs based on their parity
(primipara or multipara) and their use of IFA tablets
(user or non-user). All the mothers or mothers-in-law
of the pregnant women were also approached for inter-
view. When neither the mother-in-law nor the mother
was present, the interviewer interviewed an older female
of the family who played a similar role to the mother-in-
law or mother.
All the participants of the study provided written con-
sent and the study received ethical clearance from the
Ethical Review Committee of the International Centre
for Diarrhoeal Disease Research, Bangladesh.Data analysis
All the interviews were audio-recorded and transcribed
in Bangla for analysis by the researchers themselves. The
data obtained were manually coded for emerging themes.
Themes were triangulated using data collected through
various qualitative methods. Peer debriefing was conducted
within the study team to help understand the issues and
consolidate the findings.Results
Perceptions related to pregnancy and childbirth
Birth weight and size
In the community, people did not aspire for a certain
weight for their babies and, therefore, showed no con-
cern about birth weight. No specific terminology for
‘low birth weight’ was found. People recognised a low-
birth-weight baby by its appearance and described it as
‘immature’, ‘undeveloped’, ‘small’, or ‘light’. The preg-
nant women and their mothers-in-law were concerned
about having a healthy baby rather than aspiring for a
baby of a certain weight. They perceived a ‘normal’,
healthy baby to look ‘natural’, be able to feed, cry, and
move as expected for a newborn baby. Pregnant women
were more concerned about caring for a baby after its
birth than by its weight at birth:
Life and death [of a baby] is in the hands of Allah
(sic). Even a small baby born in seven months (sic)
[of gestation] can survive if it’s given proper care. – a
pregnant woman
Most husbands desired a large baby with a healthy ap-
pearance, while wives wished for smaller babies as it
would mean ‘less suffering’ during birth, uncomplicated
delivery, and reduce the need for surgery. Discussion
among family members about the size and weight of the
baby at birth was hindered by perceptions that by articu-
lating aspirations about the unborn child, respondents
may bring misfortune to the mother or the infant.
Development and nourishment of the foetus
Pregnant women were aware that mother’s dietary intake
nourishes the foetus. All pregnant women interviewed
perceived that the foetus receives food, blood, and nour-
ishment directly from the mother’s body. One pregnant
woman explained:
Suppose I eat adequate fruits, then the baby in my
belly will receive it (sic). If I drink a lot of milk, the
baby [in my belly] will get the milk.
Women were aware of the need to eat normal food
during pregnancy. Most pregnant women and elderly
women knew of food taboos during pregnancy. Women
learned about these ‘harmful’ foods from family members
and neighbours. Physical appearance of a food played a
role in its description as harmful. For example, coconut
and coconut water, if consumed during pregnancy, were
said to make the eyes of the baby white (blind). Husbands
did not have any knowledge about, or role in, their wife’s
diet during pregnancy. They usually deferred to the
knowledge of older women in the family. However,
some husbands thought that eating too much rice
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full stomach left little space for the foetus to grow. This
perception was also prevalent among mothers-in-law
and mothers of the pregnant women. As one husband
explained with a livestock analogy,
We know if a pregnant woman eats much (sic) the
baby inside her tummy will be smaller, for example, if
you feed a cow too much food [during pregnancy], it
will deliver a small calf.
Medication and movement during pregnancy
Some specific restrictions about taking medicine during
pregnancy were mentioned. Pregnant women mentioned
that medication for fever and worms during pregnancy
could cause abortion and stillbirth. Women said that
during pregnancy medicine should be taken according to
a doctor’s advice. Here, ‘doctor’ often referred to personnel
in the health service delivery system such as SS or SK,
without regard to their formal qualifications. Although
IFA tablets were considered medicine, pregnant women
and their family members relied on the SS, SK and doc-
tors’ advice and hence valued using the IFAs.
If the doctor knows that you have a baby in your
tummy and asks you to take [a medicine] then you
take it, otherwise don’t (sic). There is no justification
for taking a [bio-]medicine or other kind of medicine,
say herbal remedies, on one’s own. – an older women.
Women believed that going out of the house during
certain times of the day and on certain days of the week
was harmful for pregnant women. For example, respon-
dents considered noon, sunset, and after the call for
evening prayer (esher aajan) to be harmful times. Some
considered Saturday and Tuesday to be harmful for preg-
nant women to be out of the house. It was believed that
going outside the house during these times or days would
pose the danger of being exposed to ‘bad air’ and evil eyes,
causing the death of the foetus. Further, it was considered
shameful to display the state of pregnancy to men outside
the family. These perceptions reduced the mobility of the
pregnant women.
Benefits of taking IFA supplements
Very few women were aware of the clinical term ‘an-
aemia’ or how to prevent it. However, many women
were aware of the benefits of antenatal intake of iron
supplements. Women who used IFA tablets during preg-
nancy reported more strength, increased blood volume,
and reduced physical weakness. The family members of
users of IFA tablets perceived that antenatal IFA supple-
mentation increases blood volume and cleans the blood
(rokto baraye and rokto porishkar kore) for pregnantwomen. There was a common belief that during preg-
nancy women share their blood with the foetus leaving
less blood available for the mother. IFA tablets were be-
lieved to make up for this deficiency. As one pregnant
respondent said,
One should take iron tablet [during pregnancy]. When
there is a baby in the tummy, the volume of blood is
reduced in the body. So iron tablet (sic) should be
taken to make up this deficiency.
Some respondents believed that taking IFA tablets re-
duced nutrient deficiency and helped recovery from blood
loss during pregnancy. According to one elderly woman,
We are poor people. We can’t afford proper food. We
can’t afford fruits as it should be. The amount of
blood the baby (foetus) ‘eats’ goes from mother’s body.
Mother loses this amount of blood. If she takes iron
tablets, she can recover this loss. (sic)
It is important to note that women who did not take
IFA supplements talked about using the supplements if
they felt unwell during pregnancy.
Pregnant women's age and parity was a factor for
some differences of opinion among about IFA. Younger
and primimarous women had more a positive view of
IFA supplementation compared to older and multipar-
ous women. Further, a few mothers-in-law and mothers
of pregnant women perceived that taking IFA supple-
ments during pregnancy increases the size of the unborn
baby which, in turn, can pose an increased risk of birth
complications and additional costs because of necessary
hospitalisation and surgery. As a result they did not allow
their daughters-in-law or daughters to take IFAs.
…then I visited [my] baper bari (parental home).
People there scared me. They said that if I take iron
tablet, the baby in my tummy will become bigger and
difficult to deliver. – a pregnant woman
Experience of taking IFA supplements
Pregnant women who had taken IFA tablets during preg-
nancy reported positive experiences. They mentioned feel-
ing healthier and stronger after starting the supplements.
Since I have been using it [IFA tablet] (sic), I don’t feel
weakness. I used to feel weak, but now I don’t. – a
pregnant woman
When asked about the kinds of supplements they would
like to take, most women preferred capsules to tablets as
the tablets did not smell good to them. A few women pre-
ferred tablets as they are smaller than capsules and,
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experiencing the side effects of IFA supplementation,
such as nausea and vomiting, diarrhoea, constipation,
and blackened stool. SKs however, mentioned that some-
times women mistook usual pregnancy related nausea and
vomiting for side effects of IFA supplementation.
Sources of IFAs and of information
The SSs and the SKs were the main sources of informa-
tion about, and supply of, antenatal IFA supplements for
pregnant women. During routine home visits, SSs coun-
selled pregnant women about IFA tablets and sold them
to those who wanted them. Additionally, almost all of
the pregnant women mentioned hearing about IFA tab-
let consumption during pregnancy from other women in
their social networks and media (radio and television),
which helped them to accept the IFA tablets. Adolescent
female students talked of learning about the use of IFA
supplements during pregnancy from their social networks,
demonstrating that knowledge about IFA tablets during
pregnancy was widespread among women. As one re-
spondent said,
I heard about iron tablet from my sister when she was
taking it, and she heard about it from her mother-
in-law (sic).
Pregnant women were advised about taking IFA tablets
from informal (allopathic, homeopathic, and traditional
medical practitioners, and drug sellers) and formal health-
care providers (gynaecologists). However, they did not
mention receiving counselling about the need for IFA
from these sources. Interestingly, none of the women
interviewed talked about the primary government facility
or Community Clinics as a source of information or sup-
ply of IFA tablets. During our observation of Community
Clinics, two pregnant women attended the facilities with
health problems. None of them received counselling about
IFA tablets. One woman was given three tablets to take
and asked to come back for more. When we asked why
only three tablets were given, the health worker told us
that she wanted to make sure that the pregnant woman
did not waste the medication. She also told us that she
likes to provide the medication to all women who visited
the clinic, but was worried that there was not enough
stock to provide a month’s supply to each woman.
Although SSs advised the pregnant women to take IFA
supplements, they lacked a nuanced understanding of
why IFA tablets are needed during pregnancy. They them-
selves were unsure about the link between IFA tablets and
delivery complications. As a result they often simply
followed the instructions from their supervisors (SKs) and
sold the supplements to the pregnant women without try-
ing to convince them through counselling. Further, SSsdid not have adequate training in terms of managing the
side effects of IFA tablets. If some women complained
about side effects, the SSs asked the women to reduce the
frequency of the supplementation and if that did not
work they advised the women to stop taking the supple-
ments. This management strategy was based on what
the SS felt made most sense, rather than being based on
medical training.
Influence on decision-making
According to the pregnant women, BRAC SSs and SKs
were very influential in their decisions about taking IFA
tablets. Most women knew the SSs and SKs and trusted
them as providers of reliable health information. Women
mentioned that they would take IFA if the Shasthya kormi
(health workers, referring to the SS and SK) advised them
to do so. Women’s IFA supplementation coincided with
household visits by the health workers.
If ShasthyaKormi Apa tells that [a pregnant woman]
should take iron tablets, they will take it. … But they
visit from the fifth month [of pregnancy] (sic). If they
visited earlier, we would start [iron tablets] earlier. – a
pregnant woman.
At the household-level, mothers-in-law had very strong
influence in deciding whether pregnant women would
consume IFA supplements. These older women were both
sources of advice and support for the pregnant women, as
well as being in many cases the gatekeepers. For many
families mothers-in-law were in charge of family finances;
when it came to buying IFA tablets from the SSs, this role
came into play. Husbands had little role in decisions
regarding pregnancy care; pregnancy was considered a fe-
male domain and the husbands usually deferred to the
opinions of older women in the family and that of the
pregnant women themselves. When it came to money
matters, however, husbands were involved and were con-
sidered the most important decision-makers.
Barriers to early antenatal IFA supplementation
Our data did not indicate strong resistance from the
community to taking IFA supplements early in preg-
nancy, if supported by SS and SK. A few women how-
ever, expressed concern about the link between intake
of IFA supplements during pregnancy and large babies.
This concern was expressed by both pregnant women
and mothers-in-law. However, these concerns were linked
to consumption of IFA tablets generally, rather than to the
timing of IFA consumption specifically. As one pregnant
woman said,
If you eat much [during pregnancy] the baby in the
tummy gets bigger. If you take iron tablet your
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for delivery.
Although the common practice is to start the supple-
mentation around the fifth month of the pregnancy, this
practice reflected the usual time of the first antenatal
visit in the community and programme decisions made
by the BRAC Health Programme. Most pregnant women
and their family members, as well as health workers
interviewed in this study, indicated that earlier initiation
of antenatal IFA supplementation would not be opposed
by the community. However, specific concerns about
early supplementation were mentioned by the health care
providers and programme managers. The programme
managers were concerned that the community would hold
the programme responsible for any premature births or
miscarriages among women who took IFAs early in preg-
nancy on health workers’ advice. As indicated by a partici-
pant SK during FGD:
We forbid [the women] to take iron tablet during the
first three months, [because] if any abortion happens
during this period they will think that it happened due
to intake of iron tablet (sic).
A local gynaecologist when interviewed was reluctant to
prescribe IFAs during the first trimester of pregnancy as
she worried about losing a patient due to the side effects
of IFA tablets. During the first stage of pregnancy, the
doctor preferred to provide only folic acid supplements.
I don’t prescribe iron-folic acid in the first trimester.
As I said, vomiting tendency sustains for three months.
After that vomiting tendency reduces, pregnancy
hormones reduce. Then she (pregnant woman) can
accept it (IFA supplements). If she vomits, iron
deficiency will increase. – a gynaecologist
Discussion and conclusions
This paper explores the cultural and programmatic feasi-
bility of providing IFA tablets early in pregnancy in rural
Bangladesh. Understanding potential feasibility will benefit
programmes both in Bangladesh and in other low- and
middle-income countries [3]. Table 2 contains a list of
programmatic implementations of the qualitative insights
for intervention on early initiation of IFA supplements
during pregnancy.
Our study revealed that there is no local term for ‘low
birth weight’ in Bangla (the language spoken by the study
community). Although this could indicate a lack of ex-
pectation around a specific or minimal birth weight, fam-
ilies did express concern about having a healthy infant.
This community-level lack of concern regarding birth
weight is in direct contrast to scientific literature, wherelow birth weight is associated with increased morbidity
and mortality among infants [14]. On the other hand,
large babies were associated with birth complications and
increased financial burden to the family. Similar concerns
about large babies were reported by other researchers
[25-27]. In IFA supplementation programmes, therefore, it
is important to inform the community about the health
risks associated with low-birth-weight babies and the role
of IFA tablets in reducing incidence of low birth weight.
The pregnant women also need to be reassured about the
perceived link between IFA supplementation and large ba-
bies as concern about delivering large infants was shown
in both Bangladesh and other countries [25,27,28].
From interviews with women and health workers it is
apparent that front-line health workers need better train-
ing for awareness and management of side effects of IFA
supplements. Prior studies conducted in Bangladesh [29]
and Cambodia [30] have concluded that efforts to further
reduce side effects may not be successful in improving
compliance of antenatal iron supplementation. However,
those studies did not take into account the importance of
increasing awareness about possible side effects and man-
agement of the side effects. Our study and other studies
suggests that providing women with more information
about possible side effects and educating them about
managing those side effects can potentially improve
compliance [25].
Our study supported the findings of other studies in
low and middle resource setting about a lack of know-
ledge on maternal anaemia and beliefs restricting certain
nutritious foods that could benefit healthy pregnancies
[28,30,31]. These findings demonstrate the necessity of
providing better and comprehensive counselling for preg-
nant women, and making the IFA tablets accessible. Using
CHWs who live in the community and are trusted by
community members could enhance programme effect-
iveness, as has been seen in other maternal and neonatal
health programmes [32,33] and IFA supplementation pro-
grammes [34,35]. It is important to note that acceptability
of the health worker to the community does not guarantee
the delivery of adequate information to the patients [25].
Experience from South East Asia and Africa shows [30,36]
that health workers require proper training to effectively
counsel pregnant women.
Positive perceptions and cultural beliefs about IFA in-
take – such as increased volume and quality of blood
and physical well-being – can promote adherence to the
supplementation regimen. Interestingly, these same per-
ceptions have been found in India, Senegal, and several
other low and middle resource settings [26,28,37]. Al-
though the SS and SK are the prime sources of informa-
tion about iron supplements and their role in pregnant
women’s health for most respondents in our study area,
some younger women had received information from
Table 2 Programmatic implications for intervention
Areas of interest Constraints and barriers Favourable factors Opportunities for intervention
Perception of birth
weight
• No desired minimum or
maximum birth weight and size
for their unborn baby.
Women desire a ‘normal’ and
‘healthy’ baby.
Training SS and SKs to:
• Discussions about the condition
of an unborn child are
perceived to be harmful.
• convey messages about the
importance of normal birth
weight and role of IFA and
• discuss the risks associated with
low birth weight and how
anaemia is linked to low birth
weight.
Perception of size of the
baby
Concerns that a large baby
would create delivery
complications.
Promote awareness that a big
baby does not necessarily create
birth complications if the mother
remains healthy during
pregnancy and appropriate
antenatal care is received.
Perception of antenatal
iron-folic acid intake
• Perceived to increase the size of
the foetus resulting in increased
birth complications and
potential surgery.
• IFA is perceived to increase
volume and quality of blood,
which helps women recover
from blood loss during
childbirth, and retain their
physical strength.
Training SS and SKs to enable
them to:
• Higher parity women are less
positive about iron-folic acid
intake.
• Younger and first-time pregnant
women tend to follow advice
of health workers sincerely.
• take available opportunities
such as community events to
improve awareness of antenatal
IFA intake in community.
Negative impression among few
older females.
• counsel pregnant women
about impact of IFA on the
growth of foetus in greater
detail.
• use existing favourable cultural
reasoning in the promotion of
antenatal IFA supplementation.
• target older and multiparous
pregnant women for
counselling
• include older women in the
household in the counselling
sessions.
Experience IFA intake • Side effects are experienced by
pregnant women.
• Many women do not consider
these side effects very serious.
• Use a formulation of iron-folic
acid with minimal smell
• Smell of IFA supplements is
difficult to stand for many
pregnant women.
• No concern about colour of the
supplement.
• Train SS and SKs to provide
better counselling about
possible side effects and
management of side effects
Sources of information on
iron-folic acid
• In rare cases, pregnant
women receive negative and
discouraging information about
IFA from their social network.
• Many currently pregnant
women heard about IFA at
younger age and before they
were pregnant from the
pregnant women in the family
and neighbourhood.
• SS and SK of BRAC should be
used to distribute and counsel
about IFAs.
• SS and SK are the main sources
of information on antenatal IFA
intake.
• The SS and SKs should be
trained to deal with negative





Husbands have little concern
about their wife taking IFA and
consider it a female domain.
Mothers-in-law have the
strongest influence in decision-
making.
Mothers-in-law should be
counselled in the few initial
home visits after IFA
supplements are supplied.
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Table 2 Programmatic implications for intervention (Continued)
Concerns of IFA early in
pregnancy
• SS/SK: Concerns that the
community might hold the
overall BRAC health programme
responsible for any miscarriage/
abortion that happens to a
women who was taking iron-
folic acid supplements early in
pregnancy on their advice.
• Widespread opinion exists
among pregnant women in
favour of starting IFA intake as
early as a BRAC SS/SK advises.
• Distribute iron-folic acid
supplement and provide
instructions to use through
BRAC SSs/SKs who have already
established their trustworthiness
in the community.
• BRAC Managers at Upazila level
are confident about the ability
of SS/SKs to motivate their
clients to start IFA according to
the Programme’s decision.




Medical pluralism Multiple sources of IFA
supplements and information
exists
Pregnant women usually visit
private practitioners only when
they are sick.
Maintain cordial relationship and
organise periodical stakeholders
meetings with providers outside
BRAC Health Program to align
messages about early IFA
supplementation
Costs Women wanted to have access
to free IFA supplements.
The Shonjibon project has
resources for free provision of
IFA supplements.
Provide IFA supplements free of
cost to reduce economic burden
on the family.
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prior to marriage or pregnancy. In addition to being
sources of information, family members play a role in
deciding whether or not a pregnant woman will take the
supplements, as seen in others settings also [26,37]. In
our study, we found strong influence of the mothers-in-
law and weak influence of husbands in women’s decision-
making about IFA intake. Based on the evidence about the
family members’ influence on women’s knowledge and
decision-making, our study recommends the inclusion of
family members, particularly older women and mothers-
in-law, during the counselling of the pregnant women.
Our study showed older and multiparous pregnant
women were less likely to take IFA tablets and listen to
advice. This finding is contradictory to a few other stud-
ies [30,38], but is supported by recent Bangladesh Health
and Demographic Survey results [39]. It is important,
therefore, that any programme aiming to increase com-
pliance with the taking of IFA tablets target pregnant
women based on age and parity.
In the study, community antenatal care and IFA tablets
were received from multiple sources, similar to other set-
tings [31,35], which indicates a need to standardize health
information about IFA tablets in order to increase the
coverage and acceptance of IFA supplementation. This is
particularly relevant if IFA supplementation is started in
the first trimester of pregnancy. In our study, neither for-
mal doctors nor NGO healthcare providers reach out to
pregnant women before the second trimester. And both
groups expressed concerns about prescribing IFA supple-
mentation in early pregnancy. It is important, then, to train
both NGO workers and local private practitioners about
the value of early IFA supplementation, so that all pro-
viders trusted by the community are supportive of IFA pro-
grammes. To acquire this support efforts should be madeto communicate regularly and maintain good relationships
with the providers outside the programme [31,40]. For the
implementer of early IFA supplementation programmes, it
is crucial to train their managers and field workers about
the need for early IFA supplementation, and adequately
address their concerns regarding all aspects of the
programme. A strong effort to create buy-in from the
personnel actually implementing the programmes will
be crucial for the success of the programme.
Our study has some limitations that would be consid-
ered when interpreting the results of the study. As a for-
mative and qualitative study, the results are not intended
to be representative of all rural settings in Bangladesh.
Further validation would be needed to assess program-
matic feasibility of providing IFA supplementation early
in pregnancy in the rural communities with specifically
distinct characteristics such as non-Bengali speaking eth-
nic groups.
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